Repeated radioembolization in advanced liver cancer

BACKGROUND: To evaluate safety and clinical outcome of repeated transarterial (90)Y (yttrium) radioembolization (TARE) in primary and metastatic liver cancer. METHODS: Between 2009 and 2018, n=288 patients underwent TARE for treatment of malignant liver disease in a tertiary care hospital. This retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Masthoff, Max, Schindler, Philipp, Harders, Fabian, Heindel, Walter, Wilms, Christian, Schmidt, Hartmut H., Pascher, Andreas, Stegger, Lars, Rahbar, Kambiz, Wildgruber, Moritz, Köhler, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575953/
https://www.ncbi.nlm.nih.gov/pubmed/33145274
http://dx.doi.org/10.21037/atm-20-2658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575953/
https://www.ncbi.nlm.nih.gov/pubmed/33145274
http://dx.doi.org/10.21037/atm-20-2658

Ejemplares similares